Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

PRAXPRAX
8 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in PRAXIS PRECISION MEDICINES I

No. RA Capital Management exited its PRAX (Praxis Precision Medicines) position in Q2 2026. Its Q1 2026 13F listed 373,787 shares worth $120.4M. RA Capital Management first reported PRAX in Q1 2024 and held it in 6 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$50.5M

Total Shares Change

-828,380

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$334.79
0
2026-Q1
Unchanged
373,787
0.0%
$120.4M1.3%$318.22
0
2025-Q4
New
373,787
-
$110.2M1.1%$297.02
69
2025-Q1
Exited
0
-100.0%
$00.0%$38.66
0
2024-Q4
Unchanged
761,955
0.0%
$58.6M0.8%$76.26
0
2024-Q3
Decreased
761,955
-38.3%
$43.8M0.5%$57.83
0
2024-Q2
Increased
1.2M
+49.2%
$51.1M0.7%$41.36
57
2024-Q1
New
828,380
-
$50.5M0.6%$61.02
57

Other major holders of PRAX: Jupiter Topco LLC, Janus Henderson Group Ltd., Orbis Allan Gray Ltd, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used